<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(21)</volume><submitter>Chen J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>This observational study aimed to share our experience in the surgical management of atrial functional mitral regurgitation (AFMR).&lt;h4>Methods&lt;/h4>We retrospectively identified 82 AFMR patients (63.6±7.7 years) from June 2008 to November 2018 at our institution. Of these patients, 72.0% of them were classified as NYHA functional class III/IV, and all of them had persistent AF. All patients underwent mitral valve (MV) repair, and 52 (63.4%) received concomitant surgical ablation (SA). Patients were followed up for 26.1±27.6 months, and postoperative mitral regurgitation (MR) was assessed by echocardiography.&lt;h4>Results&lt;/h4>There was no in-hospital mortality. The overall 1-year and 3-year survival rates were 97.5% and 92.9%, respectively, and 96.1% of patients recovered to</pubmed_abstract><journal>Annals of translational medicine</journal><pagination>1420</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7723636</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mitral valve repair and surgical ablation for atrial functional mitral regurgitation.</pubmed_title><pmcid>PMC7723636</pmcid><pubmed_authors>Ding W</pubmed_authors><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Lv M</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Hong T</pubmed_authors><pubmed_authors>Lin Y</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Wei L</pubmed_authors><pubmed_authors>Zhu S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mitral valve repair and surgical ablation for atrial functional mitral regurgitation.</name><description>&lt;h4>Background&lt;/h4>This observational study aimed to share our experience in the surgical management of atrial functional mitral regurgitation (AFMR).&lt;h4>Methods&lt;/h4>We retrospectively identified 82 AFMR patients (63.6±7.7 years) from June 2008 to November 2018 at our institution. Of these patients, 72.0% of them were classified as NYHA functional class III/IV, and all of them had persistent AF. All patients underwent mitral valve (MV) repair, and 52 (63.4%) received concomitant surgical ablation (SA). Patients were followed up for 26.1±27.6 months, and postoperative mitral regurgitation (MR) was assessed by echocardiography.&lt;h4>Results&lt;/h4>There was no in-hospital mortality. The overall 1-year and 3-year survival rates were 97.5% and 92.9%, respectively, and 96.1% of patients recovered to</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Nov</publication><modification>2025-04-04T23:46:51.213Z</modification><creation>2025-04-04T23:46:51.213Z</creation></dates><accession>S-EPMC7723636</accession><cross_references><pubmed>33313165</pubmed><doi>10.21037/atm-20-2958</doi></cross_references></HashMap>